Pharmaceutical Drug Monopolies in Mexico

SWOT Threat: Pharmaceutical Drug Monopolies in Mexico
Mexico's battle with narcotics gangs allows other types crimes to expand, because resources are spread thin. "In late February the countries' antitrust regulators uncovered schemes involving six firms to rig the bidding to provide insulin and other supplies to the health service." Every company agreed that five companies would price a specific product within 1.5% of each other, while one company offered the same product for slightly less. The companies would choose a different product to offer at the lowest price which cost taxpayers an estimated $46 million dollars between 2003 and 2006. This form of collusion cost the government millions.